Moreover, breast cancers harboring MMR germline variants exhibit distinct clinical characteristics compared to their wildtype counterparts, including a higher prevalence of high tumor grade and worse prognosis [10,11,12,15,16]. The gene discussed is MRC1; the disease is breast cancer.